熱門資訊> 正文
LakeShore Bizerma收到Oceanpine Capital的0.86美元/股收购提案
2025-08-18 21:04
- 纳比特(NA) 0
- 盛大科技(SDA) 0
- 湖岸生物製藥(LSB) 0
- Oceanpine Capital submitted a preliminary non-binding proposal to acquire all outstanding shares of LakeShore Biopharma (NASDAQ:LSB) not already owned.
- The proposed all-cash offer is $0.86/share, representing a 10.3% premium to the August 15, 2025, closing price and 11.4% premium to the 15-day average.
- The transaction would be funded by rollover equity and available cash, with no financing condition.
- LakeShore’s board will evaluate the proposal.
- LSB shares up 1.3% premarket on Monday.
- Source: Press release
More on LakeShore Biopharma
- Financial information for LakeShore Biopharma
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
